This year marks the 25th anniversary of the Ataxia Unit, and in celebrating Jeremy Schmahmann, MD, is now launching the Ataxia Center, which seeks to provide comprehensive, personalized and patient-centered care for those with ataxia.
Mass General’s Marian DiFiglia, PhD, is working to advance research on the rare genetic mutation that affects her grandson.
Research Roundup: Genetic Protection from Alzheimer’s Disease, Football Players and Heart Health, and More
Recent research news from the Mass General Research Institute, including insights into genetic protection from Alzheimer’s disease, heart health and more.
DISCOVERY will become a landmark study to unravel the mechanisms of post-stroke cognitive disability and to identify treatment targets.
As part of the High-Risk, High-Reward Research program, the NIH New Innovator Award supports exceptionally creative early career investigators who propose innovative, high-impact projects in the biomedical, behavioral or social sciences within the NIH mission. This year, three Mass General investigators were named NIH New Innovators.
Alzheimer’s Disease Expert Says Future Treatment Success Will Require a Shift in Strategy and Timing
Rudy Tanzi, PhD, believes the key to treating Alzheimer’s disease will be earlier detection and treatment guided by individual risk factors and family history.
The second annual Neuroscience Day took place under the Bulfinch tent earlier this month, with a series of speakers, research presentations and an electronic poster session highlighting recent advances.
What if there was a simple way to help individuals prioritize their emotional health just as much as their physical health? As a clinical psychology intern at Massachusetts General Hospital over a decade ago, Ana-Maria Vranceanu, PhD, found herself asking this question about the orthopedic surgery patients she was caring for.
Buckner’s Death Puts New Focus on Lewy Body Dementia—A Relatively Unknown but Surprisingly Prevalent Disease
Stephen Gomperts, MD, PhD, a physician-investigator in the Department of Neurology at Massachusetts General Hospital, explains that LBD is actually an umbrella term for two different diseases—one is dementia with Lewy bodies (LBD) and the other is Parkinson’s disease with dementia, which afflicts about 30% of people with Parkinson’s disease (PD).